Clinical Trial: Continued Access to PREVAIL (CAP2)

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Continued Access to PREVAIL (CAP2)- WATCHMAN Left Atrial Appendage (LAA) Closure Technology

Brief Summary: To provide additional information about the safety and efficacy of the WATCHMAN LAA Closure Technology